Helius Therapeutics
Shweta Vagal is a skilled QA Officer with extensive experience in quality assurance within the pharmaceutical and clinical research industries. Currently, Shweta holds the position of QA Officer at Helius Therapeutics since August 2021. Prior to this role, Shweta served as a QA Officer at Douglas Pharmaceuticals Ltd from 2017 to August 2021 and worked as a Study Coordinator at Auckland Clinical Studies for a brief period in 2016. Shweta's career began as a QA Associate at Symbion Contract Logistics from 2013 to 2016 and included a role as a Validation Associate at Fresenius Kabi Australia Pty Ltd from 2011 to 2013. Shweta’s educational background includes a Master’s Degree in Pharmacology and a Bachelor’s Degree in Neuroscience, both attained at the University of Otago.
This person is not in any offices
Helius Therapeutics
8 followers
Helius is a New Zealand-owned biotechnology company focused on medicinal cannabis research and development. The country’s largest licensed producer and the first medicinal cannabis cultivator to be certified as New Zealand Grown through Buy NZ Made Campaign, Helius a leader in this nascent market. The company operates a state-of-the-art GMP facility in Auckland with indoor controlled growing systems, integrated extraction site, an advanced cannabinoid research laboratory and manufacturing operations. Following changes in New Zealand’s regulatory environment, Helius is poised to set the standard for effective and accessible medicinal cannabis products.